75
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Total saponin of Dioscoreae hypoglaucae rhizoma ameliorates streptozotocin-induced diabetic nephropathy

, , , , &
Pages 799-810 | Published online: 24 Feb 2016

References

  • International Diabetes FederationGlobal Diabetes Plan 2011–2021 Available from: http://www.idf.org/global-diabetes-plan-2011-2021Accessed January 7, 2016
  • BadalSSDaneshFRDiabetic nephropathy: emerging biomarkers for risk assessmentDiabetes20156493063306526294427
  • LopesAAEnd-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populationsEthn Dis200919Suppl 1S1S47
  • LeeseGPSavageMWChattingtonPDThe diabetic patient with hypertensionPostgrad Med J19964652632688761497
  • MishraABhattiRSinghAAmeliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathyPlanta Med201076541241719876811
  • UK Prospective Diabetes Study GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33)Lancet1998352837853
  • BrownleeMBiochemistry and molecular cell biology of diabetic complicationsNature2001414686581382011742414
  • KaliaKSharmaSMistryKNon-enzymatic glycosylation of immunoglobulins in diabetic nephropathyClin Chim Acta20043471–216917615313155
  • NavarroJFMora-FernándezCThe role of TNF-α in diabetic nephropathy: pathogenic and therapeutic implicationsCytokine Growth Factor Rev200617644145017113815
  • TaharaATsukadaJTomuraYVasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cellsPharmacol Res200857214215018299204
  • HuYYYeSDZhaoLLHydrochloride pioglitazone decreases urinary TGF-beta1 excretion in type 2 diabeticsEur J Clin Invest201040757157420482594
  • State Pharmacopeia Committee of ChinaThe Pharmacopoeia of People’s Republic of China 2015 VersionsBeijing, ChinaChina Medical Science Press2015289
  • PoudelBLimSWKiHHNepaliSLeeYMKimDKDioscin inhibits adipogenesis through the AMPK/MAPK pathway in 3T3-L1 cells and modulates fat accumulation in obese miceInt J Mol Med20143451401140825189808
  • TaoXWanXXuYDioscin attenuates hepatic ischemia-reperfusion injury in rats through inhibition of oxidative–nitrative stress, inflammation and apoptosisTransplantation201498660461125083618
  • WuSXuHPengJPotent anti-inflammatory effect of dioscin mediated by suppression of TNF-α-induced VCAM-1, ICAM-1 and EL expression via the NF-κB pathwayBiochimie20151105627225577996
  • World Health OrganizationWorld Health Organization ChronicleGeneva, SwitzerlandWHO19855156
  • MoreeSSKavishankarGBRajeshaJAntidiabetic effect of secoisolariciresinol diglucoside in streptozotocin-induced diabetic ratsPhytomedicine2013203–423724523271000
  • SoetiknoVSariFRSukumaranVCurcumin decreases renal triglyceride accumulation through AMPK–SREBP signaling pathway in streptozotocin-induced type 1 diabetic ratsJ Nutr Biochem201324579680222898567
  • GuoCRHanFYZhangCFProtective effects of oxymatrine on experimental diabetic nephropathyPlanta Med20148041824414304
  • Van DammeBKoudstaalJMeasuring glomerular diameters tissue sectionsVirchows Arch A Pathol Anat Histol19763694283291816063
  • LiuIMTzengTFLiouSSThe amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescriptionJ Ethnopharmacol2009124221121819397971
  • YanYFangPYangMAnti-diabetic nephropathy compounds from Cinnamomum cassiaJ Ethnopharmacol201516514114725725434
  • LvSChengJSunAMesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stressDiabetes Res Clin Pract2014104114315424513119
  • QiWChenXPoronnikPTransforming growth factor-β/connective tissue growth factor axis in the kidneyInt J Biochem Cell Biol200840191317300978
  • BeisswengerPJHowellSKRussellGDetection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparationAmino Acids201446231131924036985
  • ReusserFMode of action of streptozotocinJ Bacteriol19711055805884993338
  • TjÄlveHWilanderEJohanssonE-BDistribution of labeled streptozotocin in mice: uptake and retention in pancreatic isletsJ Endocrinol197669455456133197
  • AhmedNAdvanced glycation endproducts – role in pathology of diabetic complicationsDiabetes Res Clin Pract200567132115620429
  • WuDWenWQiCAmeliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocinPhytomedicine2012198–971271822483555
  • PowellDWBertramCCCumminsTDRenal tubulointerstitial fibrosis in OVE26 type 1 diabetic miceNephron Exp Nephrol20091111e11e1919052473
  • RooneyBDonovanHGaffneyACTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathyFEBS Lett2011585353153821237163
  • ThomsonSEMcLennanSVKirwanPDRenal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathyJ Diabetes Complications200822428429418413184
  • Mensah-BrownEPKObinecheENGaladariSStreptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokinesCytokine200531318019015975818
  • Navarro-GonzalezJFMora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathyJ Am Soc Nephrol200819343344218256353
  • JonesSJonesSPhillipsAORegulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathyKidney Int20015951739174911318944
  • KanikaPManojGVijayTDineshKPA review on pharmacological and analytical aspects of diosgenin: a concise reportNat Prod Bioprospect2012224652